BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18066568)

  • 21. [A case of ovarian serous papillary adenocarcinoma combined with malignant endosalpingiosis].
    Mizutani H; Katabuchi H; Nakamura M; Matsuura K; Ito M; Okamura H
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Oct; 45(10):1139-42. PubMed ID: 8245594
    [No Abstract]   [Full Text] [Related]  

  • 22. Nodular histiocytic aggregates in the greater omentum of patients with ovarian cancer.
    Lv Y; Li P; Zheng J; Wang L; Yun J; Huang G; Yan Q; Li Z; Luo P; Li S; Harn L; Yi J; Wang Z
    Int J Surg Pathol; 2012 Apr; 20(2):178-84. PubMed ID: 22271884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
    Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
    Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas.
    Bell KA; Smith Sehdev AE; Kurman RJ
    Am J Surg Pathol; 2001 Apr; 25(4):419-32. PubMed ID: 11257616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of ovarian cancer management.
    Gaughan E; Javaid T; Cooley S; Byrne P; Gaughan G
    Ir Med J; 2006 Oct; 99(9):279-80. PubMed ID: 17144239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic ovarian serous carcinoma presenting as inflammatory breast cancer: a case report.
    Gingell D; Samuel A; Haynik D; McBee W; Kelley J; Zorn K; Bhargava R
    Int J Gynecol Pathol; 2010 May; 29(3):243-7. PubMed ID: 20407323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian serous borderline tumors with noninvasive and invasive peritoneal implants: A case report each.
    Srinivasamurthy BC; Kulandai Velu AR; Krishnan N; Patil AS
    J Cancer Res Ther; 2015; 11(3):646. PubMed ID: 26458602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Micropapillary serous carcinoma of the ovary: case report and review of literature.
    Piura B; Rabinovich A; Yanai-Inbar I
    Eur J Gynaecol Oncol; 2000; 21(4):374-6. PubMed ID: 11055486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic carcinoma of the ovary presenting as zosteriform lesions.
    Rasi A; Tajziehchi L; Shaianfar N
    Arch Iran Med; 2007 Apr; 10(2):250-2. PubMed ID: 17367234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
    Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R
    Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An extremely large, cauliflower-type, cutaneous metastasis of ovarian cancer associated with good prognosis.
    Traiman P; de Luca LA; Bacchi CE
    Gynecol Oncol; 1994 May; 53(2):239-41. PubMed ID: 8188086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous regression in recurrent epithelial ovarian cancer.
    Fujiwaki R; Sawada K
    Arch Gynecol Obstet; 2007 May; 275(5):389-91. PubMed ID: 17177031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Papillary serous carcinoma in ovaries of normal size: a clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma.
    Choi CH; Kim TJ; Kim WY; Ahn GH; Lee JW; Kim BG; Lee JH; Bae DS
    Gynecol Oncol; 2007 Jun; 105(3):762-8. PubMed ID: 17383715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal glandular smear: first evidence of ovarian malignancy.
    Lammens L; Fenton D
    J Obstet Gynaecol; 2002 Nov; 22(6):702. PubMed ID: 12554283
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma.
    Liu JF; Hirsch MS; Lee H; Matulonis UA
    Gynecol Oncol; 2009 Dec; 115(3):401-6. PubMed ID: 19796795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian carcinoma, endometrial carcinoma, and pregnancy.
    Foersterling DL; Blythe JG
    Gynecol Oncol; 1999 Mar; 72(3):425-6. PubMed ID: 10053118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical metastasis as the first manifestation of ovarian papillary serous carcinoma.
    Maki C; Groen J; Delgado B; Piura B
    J Obstet Gynaecol; 2010 Apr; 30(3):325-6. PubMed ID: 20373951
    [No Abstract]   [Full Text] [Related]  

  • 38. Stage IV micropapillary serous ovarian carcinoma: a report of three cases.
    Kim YW; Srodon M; Bristow RE
    Int J Gynecol Pathol; 2005 Jul; 24(3):235-8. PubMed ID: 15968198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Well-differentiated serous neoplasms of the ovary.
    Longacre TA; Kempson RL; Hendrickson MR
    Pathology (Phila); 1993; 1(2):255-306. PubMed ID: 9420921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal change disease in a patient with ovarian papillary serous carcinoma.
    Ryu DR; Yoo TH; Kim YT; Jeong HJ; Cho NH; Kang SW
    Gynecol Oncol; 2004 May; 93(2):554-6. PubMed ID: 15099980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.